Kidney Failure & Dialysis

Kidney Failure & Dialysis



Andreoli SP. Reactive oxygen molecules, oxidant injury and renal disease. Pediatr. Nephrol. 5: 733-742, 1991 Medline

Bonnefont-Rousselot D, Jaudon MC Issad B, et al. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant. 12:1399-1405, 1997 Medline

Breborowicz A, Rodela H. Martis L. Oreopoulos DG. Intracellular glutathione in human peritoneal mesothelial cell exposed in vitro to dialysis fluid. Int. J. Artif. Organs 19: 268-275, 1996 Medline

Canestrari F, Galli F, Giorgini A, et al. Erythrocyte redox state in uremic anemia: effects of hemodialysis and relevance of glutathione metabolism. Acta. Haematol. 91: 187-193, 1994 Medline

Cavdar C, Cansari T, Semin I, et al. Lipid peroxidation and antioxidant activity in chronic hemodialysis patients treated with recombinant human erythropoietin. Scand. J. Urol. Nephrol. 31: 371-375, 1997 Medline

Ceballos-Pict I, Witko-Sarsat V, Merad-Boudia M, et al. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure. Free Radic. Biol. Med. 21: 845-853, 1996 Medline

Chen CK, Liaw JM, Juang JG, Lin TH. Antioxidant enzymes and trace elements in hemodialyzed patients. Biol. Trace Elem. Res. 58(1-2): 140-157, 1997 Medline

Costagliola C, Romano L, Scibelli G, et al. Anemia and chronic renal failure: a therapeutic approach by reduced glutathione parenteral administration. Nephron 61: 404-408, 1992 Medline

Costagliola C, Romano L, Sorice P, Di Benedetto A. Anemia and chronic renal failure: the possible role of the oxidative state of glutathione. Nephron 52: 11-14. 1989 Medline

Cristol JP, Bose JY, Badiou S, et al. Erythropoeitin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol. Dial. Transplant 12: 2312-2317, 1997 Medline

Diamond GL, Zalups RK. Understanding renal toxicity of heavy metals. Toxicol. Pathol. 26: 92-103, 1998 Medline

DiMari J, Megyesi J, Udvarhelyi N, et al. N-acetyl cysteine ameliorates ischemic renal failure. American J. Physiol. 272 (3 pt2): F292-8, 1997 Medline

Durak I, Karabacak HI, Buyukkocak S, et al. Impaired antioxidant defense system in the kidney tissues from rabbits treated with cyclosporin. Protective effects of vitamins E and C. Nephron 78:207-211, 1998 Medline

Epperlein MM, Nourooz-Zadeh J, Jayasena SD, et al. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J. American Soc. Nephrol. 9: 457-463, 1998 Medline

Ferguson CL, Cantilena LR Jr. Mercury clearance from human plasma during in vitro dialysis: screening systems for chelating agents. J. Toxicol. Clin. Toxicol. 30: 423-441, 1992 Medline

Lund ME, Banner W Jr. Clarkson TW, Berlin M. Treatment of acute methylmercury ingestion by hemodialysis with N-acetylcysteine (Mucomyst) infusion and 2,3-dimercaptopropane sulfonate. J. Toxicol. Clin. Toxicol. 22: 31-49, 1984 Medline

Martin-Mateo MC, Del Canto-Jafiez E, Barrero-Martinez MJ. Oxidative stress in chronic renal failure. Renal. Failure 21: 155-167, 1999 Medline

Mimic-Oka J, Simic T, Elkmescic V, Dragicevic P. Erythrocyte glutathione peroxidase and superoxide dismutase activities in different stages of chronic renal failure. Clin. Nephrol. 44: 44-48, 1995 Medline

Moberly JB, Logan J, Borum PR, et al. Elevation of whole-blood glutathione in peritoneal dialysis patients by L-2-oxothiazolidine-4-carboxylate, a cysteine prodrug (Procysteine). J. American Soc. Nephrol. 9:1093-1099, 1998 Medline

Ong-Awyooth L, Ong-Ajyooth S, Tiensong K, et al. Reduced free radical scavengers and chronic renal failure. J. Med. Assoc. Thai. 80:101-108, 1997 Medline

Pasaoglu H, Muhtaroglu S, Gunes M, Utas C. The role of the oxidative state of glutathione and glutathione-related enzymes in anemia of hemodialysis patients. Clin. Biochem. 29: 567-572, 1996 Medline

Ross EA, Koo LC, Moberly JB. Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. American L. Kidney Disease 30: 489-494, 1997 Medline

Roxborough HE, Mercer C, McMaster D, et al. Plasma Glutathione peroxidase activity is reduced in haemodialysis patients. Nephron 81: 278-283, 1999 Medline

Salom MG, Ramirez P, Carbonell LF, et al. Protective effect of N-acetyl-L-cysteine on the renal failure induced by inferior cava occlusion. Transplantation 65: 1315-1321, 1998 Medline

Schiavon R, Guidi GC, Biasioli S, et al. Plasma glutathione peroxidase activity as an index of renal function. Eur. J. Clin. Chem. Clin. Biochem. 32: 759-765, 1994 Medline

Torres VE, Bengal RJ, Litwiller RD, Wilson DM. Aggravation of polycystic kidney disease in Han:SPRD rats by buthionine sulfoxamine. J. American Soc. Nephrol. 8: 1283-1291, 1997 Medline

Usberti M, Lima G, Arisi M, et al. Effect of exogenous reduced glutathione on the survival of red blood cells in hemodialyzed patients. J. Nephrol. 10:261-265, 1997 Medline

Whitin JC, Tham DM, Bhamre S, et al. Plasma glutathione peroxidase  and its relationship to renal proximal tubule function. Mol. Genet. Metab. 65:238-245, 1998 Medline

Yoshimura S, Suemizu H, Nomoto Y, et al. Plasma glutathione peroxidase deficiency caused by renal dysfunction. Nephron 73: 207-211, 1996 Medline

Zachee P. Ferrant A, Daelmans R, et al. Reduced glutathione for the treatment of anemia during hemodialysis: a preliminary communcation. Nephron 71: 343-349, 1995 Medline

Leave a Reply